康臣药业12月15日斥资209.67万港元回购14万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Company Actions - The company plans to repurchase 140,000 shares at a total cost of HKD 2.0967 million [1] - The buyback price is set between HKD 14.9 and HKD 15.0 per share [1]